CsA reduces Flk1 protein expression and significantly decreases the percentages of Flk1+ cells. by Seung-Cheol Choi (686982)

PDE-5 inhibition with sildenafil decreases the amount of dipropylenetriamine NONOate (DPTA-NO) necessary to prevent ECM. by Yuri C. Martins (333396)

<i>Furin</i> mutant hearts show a decreased in the number of phospo-Smad positive cells at the AV junction. by Laurent Dupays (2940330)

phosphoATM focal intensity decreases at DSBs undergoing resection. by Verena Geuting (440327)

Pretreatment of Huh-7.5.1 cells with PF-429242 results in a dose-dependent decrease in intracellular DENV-2 NS1 protein abundance and a 3-log decrease in extracellular viral titer. by Anastasia Hyrina (3860455)

Loss of FOXP1 results in decreased number of bRGCs. by Seon Hye E. Park (16765033)

C-terminal BNIP3 phosphorylation decreases the BNIP3-OPA1 interaction at the mitochondrial membrane. by Katherine E. Liu (759143)

PPP2R5C HepKD in <i>db/db</i> mouse liver improves insulin sensitivity, decreases hyperglycemia, but worsens the dyslipidemia. by Yong-Sheng Cheng (803758)

“…<p><b>(A)</b> Hyperglycemia in <i>db/db</i> mice is decreased upon hypatocyte-specific PPP2R5C knockdown with adeno-associated virus. …”

AAV-mediated Atp6v1c1 knockdown decreased TRAP positive cells and Atp6v1c1 expression in the periodontitis lesion area. by Sheng Li (107261)

“…<p>(A) TRAP staining was used to indicate the decrease in Atp6v1c1 expression in periodontal tissues after AAV-sh-Atp6v1c1 knockdown. …”

Locations of projected refugia for all five taxa with 2°C and 4.5°C warming. by Rhosanna L. M. Jenkins (11167230)

RMSD graphs for the backbone of WT PARG1, I845V and T622M mutants. by Zen Kouchi (14898435)

SLAMF6 knock down or knock out leads to a decrease in TCR activation. by Matthew A. Dragovich (6843362)

PARP inhibition causes a decrease in Alt-EJ that is enhanced by Ku70 loss. by Sean M. Howard (687174)

“…Shown are the immunoblot signals for PARylated protein and actin after treatment of U2OS cells with 5 μM of the PARPi Olaparib (2 days). Also shown is the cell cycle profile of siCTRL treated U2OS cells incubated with 5μM Olaparib (Olap), or mock treated (UN) prior to BrdU labeling and PI staining as in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1004943#pgen.1004943.g002" target="_blank">Fig. 2C</a>. …”

Impaired Ubr5 function results in increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

CaMKKβ contributes to the decrease in apoptosis conferred by ST2-104. by Yingshi Ji (9013004)

CaMKKβ is involved in ST2-104-regulated decrease in autophagy. by Yingshi Ji (9013004)

Absence of IFNAR signaling in Tregs results in decreased virus-specific CD8⁺ T cells and cytokine production. by Arunakumar Gangaplara (515129)

Promoter reporter studies for reported <i>NR5A1</i> mutations by Jana Malikova (615672)

Subjects:

Decrease of CXCL1 message and neutrophil counts in TLR4 deficient liver and after antibiotic treatment. by Amélie E. Bigorgne (2579386)

Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

“…The BLM treatment induced hyperplasia and increased the number of SP-C-positive type 2 epithelial cells. The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”